Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial

Peer Review reports

Original Submission
24 May 2020	Submitted	Original manuscript
24 May 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
24 May 2020	Editorially accepted
5 Jun 2020	Article published	10.1186/s13063-020-04451-7

Back to article page